Market Cap 3.19B
Revenue (ttm) 2.35B
Net Income (ttm) 43.23M
EPS (ttm) N/A
PE Ratio 21.46
Forward PE 19.84
Profit Margin 1.84%
Debt to Equity Ratio 0.30
Volume 341,000
Avg Vol 363,516
Day's Range N/A - N/A
Shares Out 32.82M
Stochastic %K 89%
Beta 0.94
Analysts Sell
Price Target $100.83

Company Profile

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupa...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 225 292 2031
Address:
3854 American Way, Suite A, Baton Rouge, United States
ZacksResearch
ZacksResearch Jun. 13 at 3:13 PM
$AMED's partnerships & acquisitions could generate synergies, but will they overcome macro pressures? šŸ¤” šŸ“ˆ High Patient Care star ratings boost confidence 🧬 New molecular testing initiatives with Patient Choice Labs šŸŒ Inflation & geopolitical tensions impacting costs Find out if AMED can maintain momentum in 2025 šŸ‘‰ https://www.zacks.com/commentary/2497854/heres-why-you-should-retain-amed-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2497854-body&ADID=SYND_STOCKTWITS_TWEET_2_2497854_BODY
0 Ā· Reply
ZacksResearch
ZacksResearch Jun. 13 at 1:40 PM
High ratings, but macro clouds — what should you do with $AMED? Amedisys scores strong on Quality of Patient Care and Patient Satisfaction, which is a clear positive for long-term holders. But weak macro conditions are keeping the stock under pressure. Full risk/reward snapshot here šŸ‘‰ https://www.zacks.com/stock/news/2497854/heres-why-you-should-retain-amed-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2497854-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2497854_TEASER
0 Ā· Reply
Lalaland28
Lalaland28 Jun. 5 at 1:11 AM
$UNH Amedisys inc $AMED merger still on the table
0 Ā· Reply
JarvisFlow
JarvisFlow Apr. 16 at 3:23 PM
RBC Capital has adjusted their stance on Amedisys ( $AMED ), setting the rating to Outperform with a target price of 100.
0 Ā· Reply
NVDAMillionaire
NVDAMillionaire Mar. 28 at 12:00 AM
$AMED Digging AMED's home health play. DOJ merger drama adds spice but UNH deal could be game-changer. Quality metrics looking strong. Watching closely for regulatory updates. Might add small position if dips happen. an honest look at company progress: https://beyondspx.com/article/amedisys-amed-a-home-health-and-hospice-leader-navigating-a-dynamic-industry
0 Ā· Reply
swingingtech
swingingtech Mar. 20 at 8:17 PM
$CAPR $AMED $LULU https://wallstreetwaves.com/significant-thursday-options-movement-capr-amed-lulu/
1 Ā· Reply
Aschnell001
Aschnell001 Mar. 18 at 7:29 AM
$AMED is an interesting stock. It's relatively low risk (operates in the home health, hospice, and personal care sectors, which are generally considered to have relatively stable demand) and currently has a stop-loss at around $89.50 based on the support levels. However, it relies heavily on Medicare, so any changes to Medicare policies can have a substantial impact. The green candles are probably accurate, but I'd personally wait until the share price gets past $93 and holds for a day or 2 (look at how many times it has tried and failed).
0 Ā· Reply
JarvisFlow
JarvisFlow Mar. 4 at 2:00 PM
Stephens & Co. has adjusted their stance on Amedisys ( $AMED ), setting the rating to Equal-Weight with a target price of 101.
0 Ā· Reply
ajmrtxl
ajmrtxl Feb. 28 at 4:01 PM
$AMED's latest data on SqueezeFinder
0 Ā· Reply
Estimize
Estimize Feb. 11 at 2:18 PM
Wall St is expecting 1.05 EPS for $AMED Q4 [Reporting 02/19 AMC] http://www.estimize.com/intro/amed?chart=historical&metric_name=eps&utm_co
0 Ā· Reply
Latest News on AMED
Amedisys Reports First Quarter 2025 Financial Results

Apr 23, 2025, 4:45 PM EDT - 7 weeks ago

Amedisys Reports First Quarter 2025 Financial Results


US sues to block UnitedHealth's $3.3 bln purchase of Amedisys

Nov 12, 2024, 12:03 PM EST - 7 months ago

US sues to block UnitedHealth's $3.3 bln purchase of Amedisys

UNH


Amedisys Reports Third Quarter 2024 Financial Results

Nov 6, 2024, 4:30 PM EST - 7 months ago

Amedisys Reports Third Quarter 2024 Financial Results


Amedisys Reports Second Quarter 2024 Financial Results

Jul 24, 2024, 4:30 PM EDT - 11 months ago

Amedisys Reports Second Quarter 2024 Financial Results


Amedisys Reports First Quarter 2024 Financial Results

Apr 24, 2024, 4:45 PM EDT - 1 year ago

Amedisys Reports First Quarter 2024 Financial Results


Amedisys, Inc.: Why Stock Is A Hold Pending Agency Review

Nov 3, 2023, 10:08 AM EDT - 1 year ago

Amedisys, Inc.: Why Stock Is A Hold Pending Agency Review


Amedisys Reports Third Quarter 2023 Financial Results

Oct 24, 2023, 4:30 PM EDT - 1 year ago

Amedisys Reports Third Quarter 2023 Financial Results


Amedisys Celebrates National Quality Week

Oct 18, 2023, 4:30 PM EDT - 1 year ago

Amedisys Celebrates National Quality Week


Amedisys Reports Second Quarter 2023 Financial Results

Jul 26, 2023, 4:30 PM EDT - 2 years ago

Amedisys Reports Second Quarter 2023 Financial Results


UnitedHealth Buys Amedisys for $3.3 Billion

Jun 26, 2023, 2:30 PM EDT - 2 years ago

UnitedHealth Buys Amedisys for $3.3 Billion

UNH


Amedisys Agrees to $3.3 Billion UnitedHealth Merger

Jun 26, 2023, 12:24 PM EDT - 2 years ago

Amedisys Agrees to $3.3 Billion UnitedHealth Merger

UNH


UnitedHealth Agrees All-Cash Deal to Buy Amedisys

Jun 26, 2023, 9:34 AM EDT - 2 years ago

UnitedHealth Agrees All-Cash Deal to Buy Amedisys

UNH


Amedisys, Inc. (AMED) Q4 2022 Earnings Call Transcript

Feb 16, 2023, 4:28 PM EST - 2 years ago

Amedisys, Inc. (AMED) Q4 2022 Earnings Call Transcript


Amedisys Announces Divestiture of its Personal Care Division

Feb 15, 2023, 4:10 PM EST - 2 years ago

Amedisys Announces Divestiture of its Personal Care Division


ZacksResearch
ZacksResearch Jun. 13 at 3:13 PM
$AMED's partnerships & acquisitions could generate synergies, but will they overcome macro pressures? šŸ¤” šŸ“ˆ High Patient Care star ratings boost confidence 🧬 New molecular testing initiatives with Patient Choice Labs šŸŒ Inflation & geopolitical tensions impacting costs Find out if AMED can maintain momentum in 2025 šŸ‘‰ https://www.zacks.com/commentary/2497854/heres-why-you-should-retain-amed-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2497854-body&ADID=SYND_STOCKTWITS_TWEET_2_2497854_BODY
0 Ā· Reply
ZacksResearch
ZacksResearch Jun. 13 at 1:40 PM
High ratings, but macro clouds — what should you do with $AMED? Amedisys scores strong on Quality of Patient Care and Patient Satisfaction, which is a clear positive for long-term holders. But weak macro conditions are keeping the stock under pressure. Full risk/reward snapshot here šŸ‘‰ https://www.zacks.com/stock/news/2497854/heres-why-you-should-retain-amed-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2497854-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2497854_TEASER
0 Ā· Reply
Lalaland28
Lalaland28 Jun. 5 at 1:11 AM
$UNH Amedisys inc $AMED merger still on the table
0 Ā· Reply
JarvisFlow
JarvisFlow Apr. 16 at 3:23 PM
RBC Capital has adjusted their stance on Amedisys ( $AMED ), setting the rating to Outperform with a target price of 100.
0 Ā· Reply
NVDAMillionaire
NVDAMillionaire Mar. 28 at 12:00 AM
$AMED Digging AMED's home health play. DOJ merger drama adds spice but UNH deal could be game-changer. Quality metrics looking strong. Watching closely for regulatory updates. Might add small position if dips happen. an honest look at company progress: https://beyondspx.com/article/amedisys-amed-a-home-health-and-hospice-leader-navigating-a-dynamic-industry
0 Ā· Reply
swingingtech
swingingtech Mar. 20 at 8:17 PM
$CAPR $AMED $LULU https://wallstreetwaves.com/significant-thursday-options-movement-capr-amed-lulu/
1 Ā· Reply
Aschnell001
Aschnell001 Mar. 18 at 7:29 AM
$AMED is an interesting stock. It's relatively low risk (operates in the home health, hospice, and personal care sectors, which are generally considered to have relatively stable demand) and currently has a stop-loss at around $89.50 based on the support levels. However, it relies heavily on Medicare, so any changes to Medicare policies can have a substantial impact. The green candles are probably accurate, but I'd personally wait until the share price gets past $93 and holds for a day or 2 (look at how many times it has tried and failed).
0 Ā· Reply
JarvisFlow
JarvisFlow Mar. 4 at 2:00 PM
Stephens & Co. has adjusted their stance on Amedisys ( $AMED ), setting the rating to Equal-Weight with a target price of 101.
0 Ā· Reply
ajmrtxl
ajmrtxl Feb. 28 at 4:01 PM
$AMED's latest data on SqueezeFinder
0 Ā· Reply
Estimize
Estimize Feb. 11 at 2:18 PM
Wall St is expecting 1.05 EPS for $AMED Q4 [Reporting 02/19 AMC] http://www.estimize.com/intro/amed?chart=historical&metric_name=eps&utm_co
0 Ā· Reply
Estimize
Estimize Jan. 23 at 9:06 PM
Wall St is expecting 1.12 EPS for $AMED Q1 [Reporting 04/23 AMC] http://www.estimize.com/intro/amed?chart=historical&metric_name=eps&utm_co
0 Ā· Reply
benzinga
benzinga Jan. 15 at 9:18 PM
UnitedHealth Group Q4 Earnings Preview: First Report Since Insurance CEO's Murder Comes With Questions On Company's Future $UNH $AMED $DIA https://www.benzinga.com/trading-ideas/previews/25/01/43014717/unitedhealth-group-q4-earnings-preview-first-report-since-insurance-ceos-murder
0 Ā· Reply
StockAutoPro
StockAutoPro Dec. 28 at 1:28 PM
$AMED: Healthcare resilience buy $90 sell $95 as stability drives this sector play
0 Ā· Reply
JackDarwin
JackDarwin Dec. 28 at 3:37 AM
$AMED Gap Up Formed.
0 Ā· Reply
inspector_gadget86
inspector_gadget86 Dec. 27 at 7:41 PM
$AMED $UNH the companies entered into a new waiver agreement, a filing revealed. This new agreement extends the deadline to close their $3.3 billion merger.
1 Ā· Reply
HotStockNews
HotStockNews Dec. 27 at 5:17 PM
0 Ā· Reply
theoptionsplug
theoptionsplug Dec. 27 at 5:16 PM
$UNH Daily nice bounce off of support after tragic CEO a**a**ination $508 needs to hold for a move higher $UNH and $AMED extended the deadline to Dec. 31st 2025 for closing the $3.3B merger as the US DOJ scrutinizes the deal
0 Ā· Reply
Thestocktraderhubzee
Thestocktraderhubzee Dec. 27 at 3:19 PM
$AMED Amedisys shares are trading higher after the company announced it extended its merger deadline with UnitedHealth.
0 Ā· Reply
StocktwitsNews
StocktwitsNews Dec. 27 at 3:07 PM
UnitedHealth, Amedisys Stocks In Focus As $3.3B Merger Deadline Extended Amid DOJ Wrangling: Retail Guarded. $UNH $AMED https://stevents.onelink.me/wmCS/n4ol96z6
0 Ā· Reply
DonCorleone77
DonCorleone77 Dec. 27 at 2:11 PM
$SRFM $MYSZ $AMED $FAST $PRFX Feel free to follow me for pre-market and after-hours movers every day. PRE-MARKET MOVERS: Currently Higher: -- Surf Air Mobility (SRFM) up 22.4% after announcing board members purchased company stock -- My Size (MYSZ) up 125.8% after announcing they anticipate closing 2024 with $8.5M in revenue -- Arena Group (AREN) up 17.6% after the company's plan to regain compliance with NYSE American's continued listing standards had been accepted -- Amedisys (AMED) up 4.7% after entering into a waiver pursuant to which, among other things, Amedisys and UnitedHealth Group (UNH) each waived its right to terminate the merger agreement -- HomeStreet (HMST) up 0.6% after announcing that the bank entered into an agreement to sell to Bank of America (BAC) $990M of multifamily commercial real estate loans, at a price, including the value of the retained servicing, of 92% of the principal balance of the loans Currently Lower: -- Fastenal (FAST) down 0.5% after disclosing that Holden Lewis, the senior executive VP and CFO of Fastenal, provided written notice to the company of his resignation, effective on April 16, 2025 -- PainReform (PRFX) down 19.4% after the company reported that following further investigation, PainReform has determined that the data from the final 24-hour period could not be clarified to satisfy the study's primary endpoint 72 hours requirement
0 Ā· Reply
OpenOutcrier
OpenOutcrier Dec. 27 at 1:32 PM
$AMED (+4.4% pre) $UNH UnitedHealth, Amedisys extend deadline to close $3.3 billion deal - Reuters https://ooc.bz/l/51817
0 Ā· Reply